NT Pharma Revenue and Competitors
Estimated Revenue & Valuation
- NT Pharma's estimated annual revenue is currently $2.6M per year.
- NT Pharma's estimated revenue per employee is $201,000
Employee Data
- NT Pharma has 13 Employees.
- NT Pharma grew their employee count by -13% last year.
NT Pharma's People
| Name | Title | Email/Phone |
|---|
NT Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is NT Pharma?
Established in 1995 and headquartered in Hong Kong, NT Pharma Group is a leading vertically integrated healthcare company with extensive nationwide coverage in China and strong capabilities in production, sales and marketing and distribution of pharmaceuticals and healthcare products. The Company's main operations center in Shanghai houses key functional departments such as finance, HR, legal and corporate development, while the Company's customers and principals are served through sales subsidiaries in Shanghai, Beijing, Guangzhou, Suzhou, Taizhou and Hainan. The Company also owns and operates a new pharmaceuticals factory (built in 2009) that carries out contract manufacturing for partners and manufactures NT Pharma branded pharmaceutical products.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$2.6M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NT Pharma News
For all your welding, machining and construction requirements. Visit Site. Crowhurst Engineering. NT's Largest Surveyors. Northern Territory's...
We can see from the most recent balance sheet that China NT Pharma Group had liabilities of CN¥989.1m falling due within a year, and liabilities...
NT-proBNP, a biomarker of cardiac failure and independent predictor of mortality in ATTR-CM patients, was stable or improving throughout the...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 13 | -24% | N/A |
#2 | $1.4M | 13 | N/A | N/A |
#3 | $1.1M | 13 | N/A | N/A |
#4 | $2.1M | 13 | N/A | N/A |
#5 | $1.4M | 13 | N/A | N/A |